- Home
- ABVC
ABVC
ABVC BioPharma Inc.
as 04-23-2025 4:00pm EST
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | FREMONT |
| Market Cap: | 16.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 648.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.42 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.40 - $1.73 | Next Earning Date: | 04-15-2025 |
| Revenue: | $509,588 | Revenue Growth: | 234.31% |
| Revenue Growth (this year): | 735.18% | Revenue Growth (next year): | N/A |
Latest ABVC BioPharma Inc. News
ABVC Breaking Stock News: Dive into ABVC Ticker-Specific Updates for Smart Investing
NewMediaWire
8 days ago
UPDATE: ABVC BioPharma Announces 2024 Financial Results
NewMediaWire
9 days ago
ABVC BioPharma Announces 2024 Financial Results
NewMediaWire
21 days ago
ABVC's Subsidiary AiBtl Signs Share-for-Land Agreement in Asia With Deal Valued at USD $7.67 Million
NewMediaWire
a month ago
ABVC BioPharma Maintains Lucrative Global Licensing Agreements and Promising CDMO Acquisition, Strengthening Growth Potential
NewMediaWire
2 months ago
ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs
NewMediaWire
2 months ago
ABVC and BioLite Japan Implement Strategy to Advance Japan's Biotech Innovation Into Global Markets
NewMediaWire
2 months ago
ABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025
NewMediaWire
2 months ago
Positive Market Response in Asia Fuels Potential Revenue Growth for ABVC and BioKey, Marching Into Global Dietary Supplements Market of USD 75.35 Billion
Compare ABVC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ABVC ABVC BioPharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.